TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels.

MLA

Hong, Shengjun, et al. “TMEM106B and CPOX Are Genetic Determinants of Cerebrospinal Fluid Alzheimer’s Disease Biomarker Levels.” Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association, vol. 17, no. 10, Oct. 2021, pp. 1628–40. EBSCOhost, https://doi.org/10.1002/alz.12330.

APA

Hong, S., Dobricic, V., Ohlei, O., Bos, I., Vos, S. J. B., Prokopenko, D., Tijms, B. M., Andreasson, U., Blennow, K., Vandenberghe, R., Gabel, S., Scheltens, P., Teunissen, C. E., Engelborghs, S., Frisoni, G., Blin, O., Richardson, J. C., Bordet, R., Lleó, A., … Bertram, L. (2021). TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer’s disease biomarker levels. Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association, 17(10), 1628–1640. https://doi.org/10.1002/alz.12330

Chicago

Hong, Shengjun, Valerija Dobricic, Olena Ohlei, Isabelle Bos, Stephanie J B Vos, Dmitry Prokopenko, Betty M Tijms, et al. 2021. “TMEM106B and CPOX Are Genetic Determinants of Cerebrospinal Fluid Alzheimer’s Disease Biomarker Levels.” Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association 17 (10): 1628–40. doi:10.1002/alz.12330.